Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy

References

[1] Barker G, Lim R, Rice GE, Lappas M. Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity. J Matern Fetal Neonatal Med. 2012;25:2274–80.10.3109/14767058.2012.686540Search in Google Scholar PubMed

[2] Bashan N, Dorfman K, Tarnovscki T, Harman-Boehm I, Liberty IF, Blüher M, et al. Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology. 2007;148:2955–62.10.1210/en.2006-1369Search in Google Scholar PubMed

[3] Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148:4687–94.10.1210/en.2007-0175Search in Google Scholar PubMed

[4] Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J Clin Endocrinol Metab. 2009;94:3085–88.10.1210/jc.2008-1833Search in Google Scholar PubMed PubMed Central

[5] Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism. 2012;61:706–14.10.1016/j.metabol.2011.10.008Search in Google Scholar PubMed

[6] D’Anna R, Baviera G, Corrado F, Giordano D, De Vivo A, Nicocia G, et al. Adiponectin and insulin resistance in early- and late-onset pre-eclampsia. BJOG. 2006;113:1264–69.10.1111/j.1471-0528.2006.01078.xSearch in Google Scholar PubMed

[7] De Castro J, Sevillano J, Marciniak J, Rodriguez R, González-Martín C, Viana M, et al. Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy. Endocrinology. 2011;152:4094–105.10.1210/en.2011-0068Search in Google Scholar PubMed PubMed Central

[8] De Meeus JB, Pourrat O, Gombert J, Magnin G. C-reactive protein levels at the onset of labour and at day 3 post-partum in normal pregnancy. Clin Exp Obstet Gynecol. 1998;25:9–11.Search in Google Scholar

[9] Du XY, Zabel BA, Myles T, Allen SJ, Handel TM, Lee PP, et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J Biol Chem. 2009;284:751–58.10.1074/jbc.M805000200Search in Google Scholar PubMed PubMed Central

[10] Duan DM, Niu JM, Lei Q, et al. Serum levels of the adipokine chemerin in preeclampsia. J Perinat Med. 2011;40:121–7.Search in Google Scholar

[11] Ernst MC, Haidl ID, Zúñiga LA, Dranse HJ, Rourke JL, Zabel BA, et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology. 2012;153:672–82.10.1210/en.2011-1490Search in Google Scholar PubMed PubMed Central

[12] Ernst MC, Issa M, Goralski KB, Sinal CJ. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology. 2010;151:1998–2007.10.1210/en.2009-1098Search in Google Scholar PubMed

[13] Garces MF, Sanchez E, Acosta BJ, Angel E, Ruíz AI, Rubio-Romero JA, et al. Expression and regulation of chemerin during rat pregnancy. Placenta. 2012;33:373–78.10.1016/j.placenta.2012.02.007Search in Google Scholar

[14] Garces MF, Sanchez E, Ruíz-Parra AI, Rubio-Romero JA, Angel-Müller E, Suarez MA, et al. Serum chemerin levels during normal human pregnancy. Peptides. 2013;42C:138–43.10.1016/j.peptides.2013.01.003Search in Google Scholar

[15] Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282:28175–88.10.1074/jbc.M700793200Search in Google Scholar

[16] Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207–13.10.2337/diabetes.51.7.2207Search in Google Scholar

[17] Lehrke M, Becker A, Greif M, Stark R, Laubender RP, von Ziegler F, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol. 2009;161:339–44.10.1530/EJE-09-0380Search in Google Scholar

[18] Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Wiser A, Schiff E, et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27:77–81.10.1038/sj.jp.7211639Search in Google Scholar

[19] Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Yissachar E, Schiff E, et al. Insulin sensitivity in late gestation and early postpartum period: the role of circulating maternal adipokines. Gynecol Endocrinol. 2011;27:725–31.10.3109/09513590.2010.500426Search in Google Scholar

[20] Mazaki-Tovi S, Kasher-Meron M, Hemi R, Haas J, Gat I, Lantsberg D, et al. Chemerin is present in human cord blood and is positively correlated with birthweight. Am J Obstet Gynecol. 2012;207:412.e1–10.10.1016/j.ajog.2012.08.008Search in Google Scholar

[21] Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, et al. Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med. 2009;37:637–50.10.1515/JPM.2009.101Search in Google Scholar

[22] Meder W, Wendland M, Busmann A, Kutzleb C, Spodsberg N, John H, et al. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 2003;555:495–9.10.1016/S0014-5793(03)01312-7Search in Google Scholar

[23] Naccasha N, Gervasi MT, Chaiworapongsa T, Berman S, Yoon BH, Maymon E, et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol. 2001;185:1118–23.10.1067/mob.2001.117682Search in Google Scholar PubMed

[24] Parlee SD, McNeil JO, Muruganandan S, Sinal CJ, Goralski KB. Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes. PLoS One. 2012;7:e51072.10.1371/journal.pone.0051072Search in Google Scholar PubMed PubMed Central

[25] Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, et al. Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr. 2010;74:56–61.10.1159/000282114Search in Google Scholar PubMed

[26] Ryan EA, O’Sullivan MJ, Skyler JS. Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes. 1985;34:380–9.10.2337/diab.34.4.380Search in Google Scholar PubMed

[27] Ress C, Tschoner A, Engl J, Klaus A, Tilg H, Ebenbichler CF, et al. Effect of bariatric surgery on circulating chemerin levels. Eur J Clin Invest. 2010;40:277–80.10.1111/j.1365-2362.2010.02255.xSearch in Google Scholar PubMed

[28] Sell H, Eckel J. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? Proc Nutr Soc. 2009;68:378–84.10.1017/S0029665109990218Search in Google Scholar PubMed

[29] Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2010;95:2892–96.10.1210/jc.2009-2374Search in Google Scholar PubMed

[30] Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009;58:2731–40.10.2337/db09-0277Search in Google Scholar PubMed PubMed Central

[31] Stepan H, Philipp A, Roth I, Kralisch S, Jank A, Schaarschmidt W, et al. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul Pept. 2011;168:69–72.10.1016/j.regpep.2011.03.005Search in Google Scholar PubMed

[32] van Poppel MN, Zeck W, Ulrich D, Schest EC, Hirschmugl B, Lang U, et al. Cord blood chemerin: Differential effects of gestational diabetes mellitus and maternal obesity. Clin Endocrinol (Oxf). 2013. [Epub. ahead of print]. Published online 5 April 2013.10.1111/cen.12140Search in Google Scholar PubMed

[33] Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf). 2010;72:342–8.10.1111/j.1365-2265.2009.03664.xSearch in Google Scholar PubMed

[34] Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198:977–85.10.1084/jem.20030382Search in Google Scholar PubMed PubMed Central

[35] Zabel BA, Allen SJ, Kulig P, Allen JA, Cichy J, Handel TM, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem. 2005;280:34661–6.10.1074/jbc.M504868200Search in Google Scholar PubMed

[36] Zhang L, Sugiyama T, Murabayashi N, Umekawa T, Ma N, Kamimoto Y, et al. The inflammatory changes of adipose tissue in late pregnant mice. J Mol Endocrinol. 2011;47:157–65.10.1530/JME-11-0030Search in Google Scholar PubMed PubMed Central